FindTrial
Sign In

Study of factors related to response of treatment in adult cellulitis patients.

A prospective study on cellulitis in adult patients with analysis of the factors related to the response to treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/042320
Enrollment
100
Registered
2022-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L039- Cellulitis and acute lymphangitis,unspecified

Interventions

Intervention1: COMMON MONOTHERAPY REGIMEN: FIRST START WITH MONOTHERAPY REGIMEN AMOXYCILLIN AND CLAVUNIC ACID AND CHANGE THE THERAPY DEPENDS ON EITHER POOR RESPONSE , TOXICITY OR CULTURE REPORT. Inter

Sponsors

NO
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: AGE 18 TO 65 YRS PATIENTS WITH A DIAGNOSIS OF CELLULITIS AS PER STULBERGS CRITERIA( REDNESS, WARMTH, PAIN, AND SWELLING IN THE AFFECTED PART).

Exclusion criteria

Exclusion criteria: PATIENTS WHO WILL NOT GIVE CONSENT PATIENTS WITH HIV, HBsAg, AND HCV POSITIVE

Design outcomes

Primary

MeasureTime frame
TO KNOW THE EFFECT OF VARIOUS FACTORS SUCH AS DEMOGRAPHIC, CO-MORBIDITY, CLINICAL AND TOPOGRAPHICAL, MICROBIOLOGICAL LABORATORY, IMAZING AND DURATION OF HOSPITAL STAY IN TREATMENT RESPONSE(GOOD OR POOR) OF CELLULITIS PATIENTS.Timepoint: BASELINE, 4 WKS AND 8WKS.—

Secondary

MeasureTime frame
TO KNOW THE FACTORS RELATED TO RESPONSE TO CELLULITIS TREATMENT.Timepoint: ONE YEAR—

Countries

India

Contacts

Public ContactMUKESH KUMAR

IGIMS

drmukeshk@yahoo.com09708309952

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026